Exclusive

Publication

Byline

Location

US Patent Issued to ACADEMIA SINICA on April 21 for "PDIA4 inhibitors and use thereof for inhibiting Beta-cell pathogenesis and treating diabetes" (Taiwanese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,353, issued on April 21, was assigned to ACADEMIA SINICA (Taipei City, Taiwan). "PDIA4 inhibitors and use thereof for inhibiting Beta-cell... Read More


US Patent Issued to NEW FRONTIER LABS on April 21 for "Azelaic acid esters in the treatment or prevention of dyslipidemia and associated conditions" (Texas Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,354, issued on April 21, was assigned to NEW FRONTIER LABS LLC (San Antonio). "Azelaic acid esters in the treatment or prevention of dysli... Read More


US Patent Issued to Fidia Farmaceutici on April 21 for "HA-paclitaxel conjugate for treatment of mesothelioma" (Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,355, issued on April 21, was assigned to Fidia Farmaceutici S.p.A. (Abano Terme, Italy). "HA-paclitaxel conjugate for treatment of mesothe... Read More


US Patent Issued to PanTher Therapeutics on April 21 for "Methods of treating pancreatic cancer" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,356, issued on April 21, was assigned to PanTher Therapeutics Inc. (Watertown, Mass.). "Methods of treating pancreatic cancer" was invente... Read More


US Patent Issued on April 21 for "Bioactive supplement" (Brazilian Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,357, issued on April 21. "Bioactive supplement" was invented by Wellington Silva (Ipatinga, Brazil). According to the abstract* released ... Read More


US Patent Issued to ALIAD BIOPHARMA on April 21 for "Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,358, issued on April 21, was assigned to ALIAD BIOPHARMA (Yongin-si, South Korea). "Composition for preventing or treating nervous system ... Read More


US Patent Issued to THE KITASATO INSTITUTE, LIPOPROTEIN RESEARCH STOCKHOLM on April 21 for "Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor and pharmaceutical use therefor" (Swedish, Japanese Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,359, issued on April 21, was assigned to THE KITASATO INSTITUTE (Tokyo) and LIPOPROTEIN RESEARCH STOCKHOLM AB (Stockholm). "Proprotein con... Read More


US Patent Issued to Societe des Produits Nestle on April 21 for "Compositions and methods using xanthan gum to stabilize at least one urolithin in an aqueous matrix" (New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,360, issued on April 21, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland). "Compositions and methods using xanthan gu... Read More


US Patent Issued to Enveric Biosciences Canada on April 21 for "Carboxylated psilocybin derivatives and methods of using" (Canadian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,361, issued on April 21, was assigned to Enveric Biosciences Canada Inc. (Calgary, Canada). "Carboxylated psilocybin derivatives and metho... Read More


US Patent Issued to RVL Pharmaceuticals on April 21 for "Oxymetazoline compositions" (New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,363, issued on April 21, was assigned to RVL Pharmaceuticals Inc. (Bridgewater, N.J.). "Oxymetazoline compositions" was invented by Tina d... Read More